Hannah Deresiewicz
Investor Relations Kontakt bei FORTY SEVEN, INC.
Aktive Positionen von Hannah Deresiewicz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FORTY SEVEN, INC. | Investor Relations Kontakt | - | - |
| KALA BIO, INC. | Investor Relations Kontakt | - | - |
Stern Investor Relations, Inc.
 Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.06.2013 | - |
Karriereverlauf von Hannah Deresiewicz
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Investor Relations Contact | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KALA BIO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Finance |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
- Börse
- Insiders
- Hannah Deresiewicz
- Erfahrung
